Literature DB >> 16863472

Two-dimensional gels for toxicological drug discovery applications.

Frank A Witzmann1, Matthew R Richardson.   

Abstract

Two-dimensional gel electrophoresis (2DGE) continues to be a useful approach to study protein expression. Although liquid chromatographic and mass spectrometric approaches that overcome some of the limitations and labour intensity of 2DGE are increasingly popular, this electrophoretic approach still has exceptional relevance in toxicology. Despite the technical challenges, pharmacologists/toxicologists continue to use gel-based proteomics to assess the biological and health effects of chemical treatment and exposure. This brief review addresses the use of 2DGE-based proteomics in drug development and toxicology, emphasising its unique strengths and weaknesses, and considers recent developments in this strategy that have evolved to directly confront the issues of dynamic range and reproducibility that have previously limited the overall use of 2D electrophoresis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16863472     DOI: 10.1517/17425255.2.1.103

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  3 in total

1.  Sample complexity reduction for two-dimensional electrophoresis using solution isoelectric focusing prefractionation.

Authors:  Matthew R Richardson; Sean Liu; Heather N Ringham; Victor Chan; Frank A Witzmann
Journal:  Electrophoresis       Date:  2008-06       Impact factor: 3.535

2.  Diabetic dyslipidemia and exercise alter the plasma low-density lipoproteome in Yucatan pigs.

Authors:  Matthew R Richardson; Xianyin Lai; Joseph L Dixon; Michael Sturek; Frank A Witzmann
Journal:  Proteomics       Date:  2009-05       Impact factor: 3.984

3.  Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteins.

Authors:  Vincenzo Verdoliva; Cinzia Senatore; Maria Letizia Polci; Stefania Rossi; Martina Cordella; Giuseppe Carlucci; Paolo Marchetti; Giancarlo Antonini-Cappellini; Antonio Facchiano; Daniela D'Arcangelo; Francesco Facchiano
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.